Study: Myriad myRisk Hereditary Cancer test identifies 43 percent more patients with [Archive]

View Full Version : Study: Myriad myRisk Hereditary Cancer test identifies 43 percent more patients with

News

09-08-2014, 04:00 AM

Myriad Genetics, Inc. has announced that the Myriad myRisk™ Hereditary Cancer test significantly improved the detection of cancer-causing mutations by 46 percent in patients with breast...

More... (http://www.medicalnewstoday.com/releases/282103.php)